NALCN-FAM155A-UNC79-UNC80 Complex Stabilization

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods fail to successfully form and stabilize complexes of the Na+ leak channel non-selective protein (NALCN) with FAM155A, UNC79, and UNC80, essential for understanding and modulating their activity, which is crucial for treating neurodevelopmental disorders and other conditions.

Innovation Solution

The formation of a stable complex of NALCN, FAM155A, UNC79, and UNC80 is achieved through cryo-electron microscopy, allowing for functional assays and identification of modulators, enabling the screening of molecules that bind or modulate the complex's activity.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Stability of the object's composition

If previous methods were used to form NALCN complexes with FAM155A, UNC79, and UNC80, then the NALCN-FAM155A subcomplex could be formed, but the complete four-protein complex could not be successfully formed or stabilized

Engineering Contradiction:
Improvecomplex stabilityVSAvoidcomplex formation success
Core Design Contradiction:
Stability of the object's compositionVSReliability

Solution Approach 1:

The patent uses a nanodisc membrane mimic as an intermediary structure to stabilize the NALCN-FAM155A-UNC79-UNC80 complex. The nanodisc provides a lipid bilayer environment that mimics the native cellular membrane, allowing the complex to form and maintain stability in vitro. This intermediary structure bridges the gap between isolated protein components and functional membrane-associated complexes.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent employs cryo-electron microscopy with specific parameter settings (voltage, temperature, buffer conditions) to capture and stabilize the complex structure. By optimizing these parameters, the researchers were able to obtain high-resolution structures of the complete four-protein complex that could not be achieved with previous methods.

Inventive Principle:
Principle #35Parameter changes

2Adaptability or versatility

If the complete NALCN-FAM155A-UNC79-UNC80 complex is formed, then functional assays and modulator screening become possible, but the complexity of the system increases significantly

Engineering Contradiction:
Improvefunctional assay capabilityVSAvoidsystem complexity
Core Design Contradiction:
Adaptability or versatilityVSDevice complexity

Solution Approach 1:

The patent segments the complex formation process into manageable stages: first forming the NALCN-FAM155A core complex, then progressively adding UNC79 and UNC80. This segmented approach allows researchers to characterize each subcomplex individually while working toward the complete four-protein complex, reducing the overall complexity of the system.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent replaces traditional mechanical purification and characterization methods with cryo-electron microscopy, which allows direct visualization and structural determination of the complete complex in near-native conditions. This substitution eliminates the need for complex sequential purification steps and enables functional assays with the intact complex.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach enables the identification of modulators and binders to the NALCN-FAM155-UNC79-UNC80 complex, potentially leading to new treatments for neurodevelopmental disorders and other conditions by effectively modulating the complex's activity.

Implementation Method 1

the instant inventors have determined an overall structure of this complex at 3.3-3.1 Angstrom resolution by cryo-electron microscopy

Methodology Applied
Scientific EffectCryo-electron microscopy: Electron Beam

Data Source

PatentUS20240295565A1NALCN Channel Protein and Modulators Thereof
Publication Date: 2024.09.05 GENENTECH INC
  • US20240295565A1 patent drawing
  • US20240295565A1 patent drawing
  • US20240295565A1 patent drawing

AI summary

The present disclosure relates, inter alia, to complexes of the Na+ leak channel non-selective protein (NALCN) with FAM155A (also called FAM155; Family with sequence similarity 155 member A), UNC79 (uncoordinated 79), and UNC80 (uncoordinated 80), methods of screening for molecules that modulate the activity of the complex, and identified modulators thereof.